SANUWAVE chose LITHOMED to distribute its orthopedic products in Taiwan.
Here are five things to know:
1. SANUWAVE anticipates sales of more than $500,000 within the next three years of the partnership.
2. The distribution agreement has a maximum value of $3 million.
3. Taiwan represents the company's second market presence in Asia.
4. LITHOMED predicts SANUWAVE's orthoPACE device, equipped with patented focused shock wave technology, will do well in the Taiwanese market.
5. The orthoPACE treatments are intended for treating bone conditions that need osteogenesis or calcific joints; conditions causing painful joints; and chronic pain.